Biogen Idec Earnings Preview (BIIB)

Biogen Idec (NASDAQ: BIIB) will be releasing their earnings report tomorrow morning before the opening bell. The First Call consensus estimates are that Biogen (BIIB) will report earnings per share of $1.05 versus $0.93 in the year ago period. In today's trading, the stock fell 1.29% to close at $52.84.

Biogen Idec Inc. (BIIB) is engaged in the development, manufacturing, and commercialization of therapies. The Company’s products address diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease and psoriasis. The company's current market cap is $15.28 billion.


There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.

Post new comment

The content of this field is kept private and will not be shown publicly.